KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Current Assets (2016 - 2025)

Historic Current Assets for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q3 2025 value amounting to $10.6 billion.

  • Vertex Pharmaceuticals' Current Assets rose 780.8% to $10.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 billion, marking a year-over-year increase of 780.8%. This contributed to the annual value of $9.6 billion for FY2024, which is 3215.31% down from last year.
  • As of Q3 2025, Vertex Pharmaceuticals' Current Assets stood at $10.6 billion, which was up 780.8% from $10.4 billion recorded in Q2 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Current Assets ranged from a high of $14.7 billion in Q3 2023 and a low of $8.5 billion during Q2 2021
  • Its 5-year average for Current Assets is $11.1 billion, with a median of $10.4 billion in 2025.
  • Per our database at Business Quant, Vertex Pharmaceuticals' Current Assets skyrocketed by 5678.81% in 2021 and then crashed by 3554.63% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' Current Assets (Quarter) stood at $9.6 billion in 2021, then skyrocketed by 38.43% to $13.2 billion in 2022, then grew by 6.87% to $14.1 billion in 2023, then plummeted by 32.15% to $9.6 billion in 2024, then rose by 10.14% to $10.6 billion in 2025.
  • Its Current Assets was $10.6 billion in Q3 2025, compared to $10.4 billion in Q2 2025 and $10.0 billion in Q1 2025.